Clinical Trials Logo

Clinical Trial Summary

In this study, a lipase -sourced from a nonpyrogenic yeast, Candida rugosa, will be investigated to establish optimal TG levels in adults in a 12-week supplementation period. The investigational product provides a lipase formulation that is stable and active in acidic and neutral pH environments, while also fully digesting TGs into free fatty acids and glycerol which is beyond the scope of pancreatic lipase (Schuler et al. 2012). This will be a novel study investigating the effects of C. rugosa lipase on adults with slightly elevated TG levels.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04754373
Study type Interventional
Source BIO-CAT Microbials, LLC
Contact
Status Completed
Phase Phase 2
Start date July 13, 2018
Completion date December 6, 2021

See also
  Status Clinical Trial Phase
Terminated NCT04088240 - Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease N/A
Enrolling by invitation NCT04999462 - A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health N/A
Completed NCT04990817 - Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With Avocado N/A
Completed NCT00940966 - A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome N/A
Completed NCT01562080 - Combined Effects of Bioactive Compounds in Lipid Profile Phase 2/Phase 3
Completed NCT00535535 - Fructose-Induced Palmitate Synthesis in Overweight Subjects Phase 1
Completed NCT01562782 - Change of Fructose to Fat in South Asians N/A